Needham lowered the firm’s price target on Praxis Precision (PRAX) to $85 from $150 and keeps a Buy rating on the shares. The firm is removing Ulixa sales from its model after the company disclosed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback